Del Carmen Jeffrey (CIK 0001816477)

Latest company ownership

CPRX - CATALYST PHARMACEUTICALS, INC.

Role: Chief Commercial Officer

Shares held

14,945

Last filed at

Nov 28, 2025

Confidence Score

27.1

2025Q4

Confidence Score History

2022Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 26, 2025	Nov 28, 2025	CATALYST PHARMACEUTICALS, INC.	Chief Commercial Officer	Sell	20.0	-10,983	-73.49%	✗	$256.2K
Mar 3, 2025	Mar 5, 2025	CATALYST PHARMACEUTICALS, INC.	Chief Commercial Officer	Sell	20.0	-30,423	-100.00%	✗	$696.4K
Aug 9, 2024	Aug 13, 2024	CATALYST PHARMACEUTICALS, INC.	Chief Commercial Officer	Sell	20.0	-36,058	-59.31%	✗	$664.3K
Jun 7, 2024	Jun 11, 2024	CATALYST PHARMACEUTICALS, INC.	Chief Commercial Officer	Sell	22.5	-7,541	-29.04%	✗	$121.2K
Mar 29, 2023	Mar 30, 2023	CATALYST PHARMACEUTICALS, INC.	Chief Commercial Officer	Sell	40.0	-40,000	-72.62%	✗	$667.8K
Nov 11, 2022	Nov 15, 2022	CATALYST PHARMACEUTICALS, INC.	Chief Commercial Officer	Sell	17.5	-139,017	-100.00%	✗	$2.2M
Aug 19, 2022	Aug 22, 2022	CATALYST PHARMACEUTICALS, INC.	Chief Commercial Officer	Buy	47.5	-	0.00%	✗	$198.7K